h.fonseca

TL2 · Lublin

Contributes reviews on supplier material. Based in Lublin.

Joined 18 March 2025 · last posted 3d

78 posts, newest first. Showing up to 150.

Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #47 · Compounds › Retatrutide · 25 Jul 2026 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #22 · Evidence › Study critique · 18 Jul 2026 · 23 likes Post #20 and I disagree about the size of the effect, not about the direction. On Selection: the maintained page in the documentation commons covers the general case…
Does a peptide degrade silently, with no visual change? Replied, post #73 · Practice › Storage & stability · 18 Jul 2026 · 30 likes What I want from this peptide thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Follow-up: Sleep quality changes during weight loss Replied, post #71 · Wellbeing › Sleep · 16 Jul 2026 · 25 likes Where sleep worsened at the same time as an escalation and improved afterwards, that sequence is worth recording rather than reasoning about. It reads as pedantry until…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 3 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
CJC-1295 with and without DAC: what the modification does Replied, post #108 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 3 likes Post #107 is the version of this I will quote in future. One addition. On analysis: these are short peptides and generally straightforward chromatographically, which…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #69 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 13 likes Confirming post #68 from a second method, which matters more than confirming it from a second person. Injection-site reactions are reported more often in this family…
Aggregate verification data across the directory, with caveats Replied, post #29 · Sourcing › Independent verification · 5 Jul 2026 · 14 likes This follows post #28 rather than contradicting it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
Coming back to: Telehealth prescribing models in the US Replied, post #3 · Regional › North America · 2 Jul 2026 · 0 likes Building on the opening post rather than restating it. Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #33 · Documentation › Doc review · 30 Jun 2026 · 25 likes Worth separating two things that post #32 runs together. Check the arithmetic in every worked example by hand. A wrong worked example is worse than no example and…
What to include when your question involves a chromatogram — one year on Replied, post #51 · Start Here › How to Ask · 25 Jun 2026 · 30 likes Same experience here, different supplier, so it is at least not unique to one of them.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #55 · Outcomes › Progress reports · 5 Jun 2026 · 1 like The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence. The general answer and the answer for your…
Alcohol: what is documented and what is folklore Replied, post #26 · Practice › Interactions · 25 May 2026 · 16 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
Official shortage notices and what they authorise Replied, post #45 · Access › Shortages · 12 May 2026 · 12 likes Taking post #44 at face value and following it one step further. Official shortage notices: I would want to see the raw numbers rather than the summary before agreeing.…
Why fasting instructions for oral semaglutide are not optional advice Started this topic · Compounds › Oral incretins · 11 May 2026 · 2 likes Why fasting instructions for oral semaglutide are not optional advice I have a specific reason for asking rather than idle curiosity, and the context is below. Fasting…
How much fluid is actually needed, and how you would know Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 7 May 2026 · 22 likes Fluid intake and electrolyte intake are separate questions and drinking more water alone can make a dilutional problem worse. Not the answer, but possibly the question…
Search filters: what is missing Replied, post #51 · Meta › Site feedback · 27 Apr 2026 · 0 likes On search filters I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #51 · Practice › Administration · 22 Apr 2026 · 0 likes Taking post #48 at face value and following it one step further. Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this…
Preservatives: function, testing, and limits — one year on Replied, post #10 · Pharmacology › Formulation chemistry · 14 Apr 2026 · 10 likes The failure mode on Preservatives is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
Revisiting: Absolute versus relative contraindications Replied, post #55 · Safety › Contraindications · 30 Mar 2026 · 8 likes I would keep Absolute versus relative contraindications and the decision it usually gets used for separate in this thread. They are related and they are not the same…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #5 · Compounds › Repair & healing peptides · 28 Mar 2026 · 14 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
Gastro-oesophageal reflux: improving or worsening? Replied, post #30 · Clinical › Comorbidities · 26 Mar 2026 · 3 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #26 · Sourcing › Logistics · 26 Mar 2026 · 5 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. That much is documented. The rest…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #21 · Compounds › Repair & healing peptides · 13 Mar 2026 · 7 likes Taking post #20 at face value and following it one step further. The absence of adequately powered published randomised human trials is the central fact about BPC-157.…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #30 · Practice › Administration · 12 Mar 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #56 · Analytics › Impurities & related substances · 17 Feb 2026 · 6 likes Answering the question post #54 raises rather than the one it answers. The honest reading of a purity figure: it is an upper bound on how much of what the method could…
Mass error in ppm: the arithmetic and the caveat Replied, post #66 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #45 · Clinical › Bloodwork · 3 Feb 2026 · 17 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Tag proliferation and whether we should prune — what changed since Replied, post #5 · Meta › Site feedback · 25 Jan 2026 · 0 likes Tag proliferation came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #39 · Research Methods › N-of-1 designs · 24 Jan 2026 · 3 likes Nothing to add on the substance. Thank you for taking the question at face value.
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #48 · Documentation › Doc review · 10 Jan 2026 · 14 likes What I would check first on evidence digest is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Pen dose counters: what a click does and does not guarantee Replied, post #86 · Devices › Pens & autoinjectors · 18 Nov 2025 · 12 likes Worth separating two things that post #84 runs together. Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty.…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #50 · Compounds › Tirzepatide · 12 Nov 2025 · 19 likes The titration schedule has more steps than semaglutide's, which reflects the finer gradation used in the clinical programme rather than a pharmacological requirement…
Insurance and replacement policies, compared — the long version Replied, post #31 · Sourcing › Logistics · 25 Oct 2025 · 4 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #27 · Compounds › Semaglutide · 23 Oct 2025 · 14 likes If you are new and reading this thread for the answer to semaglutide solutions: the answer is conditional, the conditions are in the third reply, and the rest of the…
Can a home kit substitute for a laboratory report? A careful no Replied, post #22 · Analytics › Home & field testing · 2 Oct 2025 · 1 like On post #18 — agreed on the reasoning, with one qualification. Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #18 · Compounds › Semaglutide · 30 Sep 2025 · 15 likes Two things can be true about semaglutide half-life at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
Follow-up: Why appetite effects are mostly central Replied, post #47 · Pharmacology › Receptor biology · 22 Sep 2025 · 0 likes The area postrema sits outside the blood-brain barrier and is where a great deal of the nausea signalling in this class originates. That is why the effect is central…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #122 · Data & Tools › Calculators · 19 Sep 2025 · 0 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #110 · Compounds › Retatrutide · 12 Sep 2025 · 0 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. Retatrutide is investigational. Anything obtained outside a trial…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #44 · Practice › Side effects · 7 Sep 2025 · 0 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #12 · Practice › Interactions · 4 Sep 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Insomnia at a dose step: reported experiences Replied, post #7 · Wellbeing › Sleep · 27 Aug 2025 · 27 likes Picking up post #6: that is the part I would want checked first. The strongest argument against my own position on insomnia, stated as well as I can state it, since…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #99 · Clinical › Comorbidities · 23 Aug 2025 · 0 likes Post #97 put the caveat in the right place and I want to underline it. An honest declaration on Cardiovascular risk: I have a prior here and it is strong enough that…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #66 · Evidence › Journal club · 19 Aug 2025 · 10 likes Post #64 describes the usual case. This is about the unusual one. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #15 · Evidence › Journal club · 12 Aug 2025 · 3 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #88 · Compounds › Repair & healing peptides · 1 Aug 2025 · 10 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #22 · Devices › Pens & autoinjectors · 2 Jul 2025 · 2 likes Where I part company with post #18, and it is a narrow parting. Priming: most pens require priming before the first use (injecting a small amount to fill the needle and…
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #68 · Devices › Pens & autoinjectors · 16 Jun 2025 · 19 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
Reading an MS report that only gives you a single number Replied, post #104 · Analytics › Mass spectrometry · 10 Jun 2025 · 2 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. I…
[2026 update] An appeal that failed, and what I would do differently Replied, post #18 · Access › Insurance & coverage · 7 Jun 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #50 · Clinical › Comorbidities · 27 May 2025 · 17 likes If someone has run hepatic steatosis properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #34 · Evidence › Trials · 20 May 2025 · 10 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Absolute and relative effects answer different questions. Write down the event rate…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #117 · Compounds › Cagrilintide & amylin analogues · 17 May 2025 · 0 likes On post #115 — agreed on the reasoning, with one qualification. A definition problem is doing most of the work in this amylin analogue mechanism discussion. Once the…
Pregnancy as an absolute contraindication Replied, post #13 · Safety › Contraindications · 17 May 2025 · 1 like Picking up post #12: that is the part I would want checked first. The most common error here is treating a trial exclusion criterion as a contraindication. They are…
Follow-up: Documentation that appears only after payment Replied, post #42 · Sourcing › Red flags · 3 May 2025 · 6 likes Helpful, and short, which on this subject is harder than long.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #96 · Compounds › Semaglutide · 29 Apr 2025 · 5 likes An update on my earlier SELECT post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #59 · Compounds › Secretagogues & GH axis · 15 Apr 2025 · 8 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #127 · Sourcing › Regulatory · 12 Apr 2025 · 6 likes Trying to state the Research-use-only labelling position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
A well-designed study with a badly written abstract Replied, post #17 · Evidence › Study critique · 10 Apr 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Why cagrilintide alone is discussed so much less than in combination Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 24 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #103 · Sourcing › Vendor reports · 18 Mar 2025 · 25 likes One lot is one lot. It becomes a pattern at three or four, and the record is built to show which of those you are looking at. I have seen it go both ways, which is why…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #26 · Sourcing › Independent verification · 7 Mar 2025 · 29 likes Nobody has said the unglamorous part of Aggregate verification data yet, so: most of the variation is explained by things that are boring to write about and easy to…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #24 · Sourcing › Regulatory · 28 Feb 2025 · 1 like Adding the measurement that post #22 says would settle it. An indication approved for one age range does not extend to another, and paediatric extensions are separate…
Why mass spectrometry cannot tell you about an epimer Replied, post #67 · Analytics › Mass spectrometry · 23 Feb 2025 · 6 likes For anyone finding this later: the short answer on mass spectrometry is that it depends on one thing, and the rest of the thread is people identifying which thing.
Protein density versus volume when you cannot eat much Replied, post #96 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 23 likes That is the distinction I keep failing to hold on to. Written down now.
Second pass at: Regression to the mean in progress reports Replied, post #49 · Research Methods › Statistics · 8 Feb 2025 · 0 likes Since Regression keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #25 · Evidence › Meta-analyses · 28 Jan 2025 · 22 likes On post #21 — agreed on the reasoning, with one qualification. If you are new and reading this thread for the answer to Reading a meta-analysis: the answer is…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #66 · Data & Tools › Calculators · 26 Jan 2025 · 32 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.…
Recovery when intake is low: what to cut first Replied, post #78 · Nutrition & Training › Resistance training · 14 Jan 2025 · 0 likes Where somebody is losing strength rapidly, the first questions are intake, sleep and total training volume, in that order.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #147 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes Narrowing post #146, because the general version has more than one answer. Trial adherence in an oral trial with strict administration requirements is genuinely worse…
What a simple presence test is genuinely useful for — does this still hold? Started this topic · Analytics › Home & field testing · 12 Nov 2024 · 52 likes What a simple presence test is genuinely useful for — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.…
Transporting a vial for a weekend away Replied, post #19 · Practice › Storage & stability · 30 Oct 2024 · 0 likes The bit of transporting a vial that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #29 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 2 likes I would keep Buffers and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #14 · Clinical › Comorbidities · 2 Oct 2024 · 0 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Type 2 diabetes: the population with the largest evidence base for these compounds.…
About the Protein & intake category Replied, post #5 · Nutrition & Training › Protein & intake · 10 Sep 2024 · 1 like Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced. For what it is…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #41 · Practice › Dosing & titration · 7 Jul 2024 · 22 likes I will take the caveat as seriously as the claim, which is the point of putting it there.